Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2191]
News [5881]
Articles [117]
Editorials [31]
Conferences [186]
elearning [22]
Updates in head and neck cancers
Prof Jean-Pascal Machiels - University Clinic Saint-Luc, Brussels, Belgium
Updates in head and neck cancers ( Prof Jean-Pascal Machiels - University Clinic Saint-Luc, Brussels, Belgium )
22 Oct 2018
First-line pembrolizumab for recurrent/metastatic head and neck squamous cell...
Prof Barbara Burtness - Yale University School of Medicine and Yale Cancer...
First-line pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma ( Prof Barbara Burtness - Yale University School of Medicine and Yale Cancer Center New Haven, USA )
22 Oct 2018
SPLENDOUR: Added denosumab in first line adv NSCLC treatment
Dr Solange Peters - Centre Hospitalier Universitaire Vaudois, Lausanne...
SPLENDOUR: Added denosumab in first line adv NSCLC treatment ( Dr Solange Peters - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland )
22 Oct 2018
Assessing radiotherapy for men with newly diagnosed metastatic prostate cancer
Dr Chris C. Parker - The Royal Marsden, London, UK
Assessing radiotherapy for men with newly diagnosed metastatic prostate cancer ( Dr Chris C. Parker - The Royal Marsden, London, UK )
22 Oct 2018
ESMO 2018: Melanoma highlights
Dr Teresa Amaral, Will Davies
ESMO 2018: Melanoma highlights ( Dr Teresa Amaral, Will Davies )
22 Oct 2018
IMpower130: PFS and safety of adding atezolizumab to first-line NSCLC therapy
Dr Federico Cappuzzo - AUSL della Romagna-Ravenna, Ravenna, Italy
IMpower130: PFS and safety of adding atezolizumab to first-line NSCLC therapy ( Dr Federico Cappuzzo - AUSL della Romagna-Ravenna, Ravenna, Italy )
22 Oct 2018
KEYNOTE048: First line pembrolizumab for recurrent or metastatic head and neck...
Prof Barbara Burtness - Yale Cancer Center, New Haven, USA
KEYNOTE048: First line pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma ( Prof Barbara Burtness - Yale Cancer Center, New Haven, USA )
22 Oct 2018
Advances in metastatic non small cell lung cancer
Dr Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany
Advances in metastatic non small cell lung cancer ( Dr Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany )
21 Oct 2018
Use of T-VEC in early metastatic melanoma
Ms Viola Franke - Netherlands Cancer Institute, Amsterdam, Netherlands
Use of T-VEC in early metastatic melanoma ( Ms Viola Franke - Netherlands Cancer Institute, Amsterdam, Netherlands )
21 Oct 2018
PEACE: Collecting cancer tissue to solve the riddle of metastasis
Dr Mariam Jamal-Hanjani - UCL Cancer Institute and UCL Hospital, London, UK
PEACE: Collecting cancer tissue to solve the riddle of metastasis ( Dr Mariam Jamal-Hanjani - UCL Cancer Institute and UCL Hospital, London, UK )
21 Oct 2018
Comment: Radiotherapy as a treatment option for metastatic prostate cancer
Dr Ignacio Duran - Hospital Universitario Virgen del Rocío, Sevilla, Spain
Comment: Radiotherapy as a treatment option for metastatic prostate cancer ( Dr Ignacio Duran - Hospital Universitario Virgen del Rocío, Sevilla, Spain )
21 Oct 2018
Survival results from STAMPEDE, radiotherapy for prostate cancer
Dr Chris C. Parker - The Royal Marsden, London, UK
Survival results from STAMPEDE, radiotherapy for prostate cancer ( Dr Chris C. Parker - The Royal Marsden, London, UK )
21 Oct 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation